Focus: Sentia Medical Sciences is a San Diego-based biotech company specializing in novel peptide therapeutics. The company maintains a portfolio of radiopharmaceutical diagnostics in the post-LOE stage.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Sentia Medical Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Generic radiopharmaceutical with no active market protection or differentiation.
Help build intelligence for Sentia Medical Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Sentia Medical Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
Generic radiopharmaceutical with no active market protection or differentiation.
6 discontinued, 8 duplicate formulations not shown
No open positions listed yet.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub